BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28585036)

  • 21. Differential mRNA expression of glucocorticoid receptor alpha and beta is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children.
    Koga Y; Matsuzaki A; Suminoe A; Hattori H; Kanemitsu S; Hara T
    Pediatr Blood Cancer; 2005 Aug; 45(2):121-7. PubMed ID: 15704223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous detection of MDR1 and WT1 gene expression to predict the prognosis of adult acute lymphoblastic leukemia.
    Xu B; Song X; Yip NC; Xiao P; Zhang Y; Wang W; Zhou S
    Hematology; 2010 Apr; 15(2):74-80. PubMed ID: 20423567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PRAME overexpression predicted good outcome in pediatric B-cell acute lymphoblastic leukemia patients receiving chemotherapy.
    Zhang YH; Lu AD; Yang L; Li LD; Chen WM; Long LY; Zhang LP; Qin YZ
    Leuk Res; 2017 Jan; 52():43-49. PubMed ID: 27875783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL.
    van der Velden VH; Jacobs DC; Wijkhuijs AJ; Comans-Bitter WM; Willemse MJ; Hählen K; Kamps WA; van Wering ER; van Dongen JJ
    Leukemia; 2002 Aug; 16(8):1432-6. PubMed ID: 12145681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia.
    Ito C; Evans WE; McNinch L; Coustan-Smith E; Mahmoud H; Pui CH; Campana D
    J Clin Oncol; 1996 Aug; 14(8):2370-6. PubMed ID: 8708730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bortezomib Treatment can Overcome Glucocorticoid Resistance in Childhood B-cell Precursor Acute Lymphoblastic Leukemia Cell Lines.
    Junk S; Cario G; Wittner N; Stanulla M; Scherer R; Schlegelberger B; Schrappe M; von Neuhoff N; Lauten M
    Klin Padiatr; 2015 May; 227(3):123-30. PubMed ID: 25985447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of Survivin and Its Splice Variants in Pediatric Acute Lymphoblastic Leukemia.
    Eren-Keleş E; Karabulut HG; Çakmaklı HF; Adaklı B; Köse SK; Uğur-Dinçaslan H; Yavuz G; Ertem M; Tükün A
    Genet Test Mol Biomarkers; 2018 Dec; 22(12):680-685. PubMed ID: 30489176
    [No Abstract]   [Full Text] [Related]  

  • 28. Detailed gene dose analysis reveals recurrent focal gene deletions in pediatric B-cell precursor acute lymphoblastic leukemia.
    Ivanov Öfverholm I; Tran AN; Olsson L; Zachariadis V; Heyman M; Rudd E; Syk Lundberg E; Nordenskjöld M; Johansson B; Nordgren A; Barbany G
    Leuk Lymphoma; 2016 Sep; 57(9):2161-70. PubMed ID: 27090575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Fat1 cadherin is overexpressed and an independent prognostic factor for survival in paired diagnosis-relapse samples of precursor B-cell acute lymphoblastic leukemia.
    de Bock CE; Ardjmand A; Molloy TJ; Bone SM; Johnstone D; Campbell DM; Shipman KL; Yeadon TM; Holst J; Spanevello MD; Nelmes G; Catchpoole DR; Lincz LF; Boyd AW; Burns GF; Thorne RF
    Leukemia; 2012 May; 26(5):918-26. PubMed ID: 22116550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of prognostic protein biomarkers in childhood acute lymphoblastic leukemia (ALL).
    Jiang N; Kham SK; Koh GS; Suang Lim JY; Ariffin H; Chew FT; Yeoh AE
    J Proteomics; 2011 May; 74(6):843-57. PubMed ID: 21396490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of outcome by early response in childhood acute lymphoblastic leukemia.
    Möricke A; Lauten M; Beier R; Odenwald E; Stanulla M; Zimmermann M; Attarbaschi A; Niggli F; Schrappe M
    Klin Padiatr; 2013 May; 225 Suppl 1():S50-6. PubMed ID: 23700057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of microRNAs in glucocorticoid‑resistant B‑cell precursor acute lymphoblastic leukemia.
    Sakurai N; Komada Y; Hanaki R; Morimoto M; Ito T; Nakato D; Hirayama M
    Oncol Rep; 2019 Aug; 42(2):708-716. PubMed ID: 31233193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR expression profiling at diagnosis predicts relapse in pediatric precursor B-cell acute lymphoblastic leukemia.
    Avigad S; Verly IR; Lebel A; Kordi O; Shichrur K; Ohali A; Hameiri-Grossman M; Kaspers GJ; Cloos J; Fronkova E; Trka J; Luria D; Kodman Y; Mirsky H; Gaash D; Jeison M; Avrahami G; Elitzur S; Gilad G; Stark B; Yaniv I
    Genes Chromosomes Cancer; 2016 Apr; 55(4):328-39. PubMed ID: 26684414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lineage classification of childhood acute lymphoblastic leukemia according to the EGIL recommendations: results of the ALL-BFM 2000 trial.
    Ratei R; Schabath R; Karawajew L; Zimmermann M; Möricke A; Schrappe M; Ludwig WD
    Klin Padiatr; 2013 May; 225 Suppl 1():S34-9. PubMed ID: 23700065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stability of gene expression and epigenetic profiles highlights the utility of patient-derived paediatric acute lymphoblastic leukaemia xenografts for investigating molecular mechanisms of drug resistance.
    Wong NC; Bhadri VA; Maksimovic J; Parkinson-Bates M; Ng J; Craig JM; Saffery R; Lock RB
    BMC Genomics; 2014 Jun; 15(1):416. PubMed ID: 24885906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ik6 expression provides a new strategy for the therapy of acute lymphoblastic leukemia.
    Zhou F; Xu Y; Qiu Y; Wu X; Zhang Z; Jin R
    Oncol Rep; 2014 Mar; 31(3):1373-9. PubMed ID: 24402122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of new markers discriminating between myeloid and lymphoid acute leukemia.
    Haouas H; Haouas S; Uzan G; Hafsia A
    Hematology; 2010 Aug; 15(4):193-203. PubMed ID: 20670477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of zinc finger protein X-linked in childhood B lineage acute lymphoblastic leukemia].
    Wang Z; Liang HH; Li BS; Huang XH; Zhang J; Wang X; Ding LX; Jiang H
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jul; 15(7):509-13. PubMed ID: 23866268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complex MLL rearrangement in non-infiltrated bone marrow in an infant with stage II precursor B-lymphoblastic lymphoma.
    Ahlmann M; Meyer C; Marschalek R; Burkhardt B; Koehler G; Klapper W; Juergens H; Rossig C
    Eur J Haematol; 2014 Oct; 93(4):349-53. PubMed ID: 24635731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenosine deaminase and purine nucleoside phosphorylase in childhood lymphoblastic leukemia: relation with differentiation stage, in vitro drug resistance and clinical prognosis.
    Pieters R; Huismans DR; Loonen AH; Peters GJ; Hählen K; van der Does-van den Berg A; van Wering ER; Veerman AJ
    Leukemia; 1992 May; 6(5):375-80. PubMed ID: 1593902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.